Incyte INCY announced today that Hervé Hoppenot,
former President of Novartis Oncology, has been named President and
Chief Executive Officer of Incyte, effective immediately. Mr. Hoppenot,
who also will join the Incyte Board of Directors, succeeds Paul A.
Friedman, M.D. Dr. Friedman is retiring and will continue to serve on
the Board.
See full press release
Market News and Data brought to you by Benzinga APIs© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Loading...
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in